Sort
326,823 grants matching “clinical trial”
SPORE in Breast Cancer
$2,181,491Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2023 · CA
Alzheimer's dementia onset and progression in international cohorts (Amended)
$2,181,321Colin Masters · University Of Melbourne · R01 · FY2018 · AG
Targeting MSUT2 with small molecules to ameliorate pathological tau
$2,181,250Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · RF1 · FY2023 · AG
A Controlled Clinical Trial of Regadenoson in Sickle Cell Anemia
$2,181,100David G. Nathan · Dana-Farber Cancer Inst · P50 · FY2014 · HL
Mechanisms, response heterogeneity and dosing from MRI-derived electric field models in tDCS augmented cognitive training: a secondary data analysis of the ACT study
$2,180,958Adam J. Woods · University Of Florida · RF1 · FY2021 · AG
Georgia NCI Community Oncology Research Program (GA NCORP)
$2,180,936Guilherme Cantuaria · Northside Hospital Atlanta · UG1 · FY2024 · CA
Imaging and Tissue Correlates to Optimize Management of Glioblastoma
$2,180,843Susan M Chang · University Of California, San Francisco · P01 · FY2015 · CA
UTMDACC SPORE in Breast Cancer
$2,180,817Gabriel N Hortobagyi · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA
Dana-Farber/Harvard SPORE in Breast Cancer
$2,180,817James Dirk Iglehart · Dana-Farber Cancer Inst · P50 · FY2008 · CA
Dana-Farber/Harvard SPORE in Breast Cancer
$2,180,817James Dirk Iglehart · Dana-Farber Cancer Inst · P50 · FY2007 · CA
RCT OF PLANT-BASED DIET IN BREAST CANCER RECURRENCE
$2,180,739University Of California San Diego · R01 · FY2003 · CA
Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN PATHS) study
$2,180,730Emily Ai-Hua Wang · Yale University · UG1 · FY2023 · DA
Improving Medical Decision Making for Older Patients with End Stage Renal Disease
$2,180,636Michael Paasche-Orlow · Boston Medical Center · R01 · FY2022 · AG
Elafin Therapy for Lung Diseases
$2,180,554Marlene Rabinovitch · Stanford University · P01 · FY2011 · HL
SC COBRE for Translational Research Improving Musculoskeletal Health (SC-TRIMH)
$2,180,530Hai Yao · Clemson University · P20 · FY2022 · GM
Integrative analysis and modeling of human immune responses and pathologies
$2,180,475John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$2,180,389Suwat Chariyalertsak · Chiang Mai University · UM1 · FY2019 · AI
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
$2,180,043Estella M Alonso · Lurie Children'S Hospital Of Chicago · U01 · FY2025 · DK
UT M.D. Anderson Cancer Center
$2,179,856Michael Jordan Fisch · University Of Tx Md Anderson Can Ctr · U10 · FY2011 · CA
UW Autism Center of Excellence
$2,179,832Bryan H King · University Of Washington · P50 · FY2010 · HD
SPORE in Gastrointestinal Cancer
$2,179,684Alison P Klein · Johns Hopkins University · P50 · FY2015 · CA
SPORE in Prostate Cancer
$2,179,681Donald J. Tindall · Mayo Clinic Rochester · P50 · FY2008 · CA
SPORE in Prostate Cancer
$2,179,681Donald J. Tindall · Mayo Clinic Rochester · P50 · FY2009 · CA
SPORE in Prostate Cancer
$2,179,681Donald J. Tindall · Mayo Clinic Rochester · P50 · FY2010 · CA
Dana-Farber/Harvard SPORE in Breast Cancer
$2,179,546Eric P Winer · Dana-Farber Cancer Inst · P50 · FY2009 · CA